Concepedia

Armin Hatzelmann

AH

Statistics

Publications

51

Citations

4K

H-Index

38

Active since

1987

Affiliations

University of Konstanz(Current)

Klinikum Konstanz

Bayer (Germany)

Altana (Netherlands)

University of Southampton

Armin Hatzelmann is an author at University of Konstanz specializing in pharmacology, life sciences, and phosphodiesterase inhibition.

Publications per year

1987–2010

51

Publications

51

Anti-Inflammatory and Immunomodulatory Potential of the Novel PDE4 Inhibitor Roflumilast in Vitro

Armin Hatzelmann, Christian Schudt · Journal of Pharmacology and Experimental Therapeutics · 2001 · 398 citations

, , +10

Potent Inhibition of Ca2+ Release-activated Ca2+ Channels and T-lymphocyte Activation by the Pyrazole Derivative BTP2

Christof Zitt, Eva C. Schwarz, Nicola Spaeth et al. · Journal of Biological Chemistry · 2004 · 291 citations · Full text

, , +15

In Vivo Efficacy in Airway Disease Models of Roflumilast, a Novel Orally Active PDE4 Inhibitor

Daniela S. Bundschuh, Manfrid Eltze, Johannes Barsig et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 239 citations

, , +16

Effects of the soluble guanylyl cyclase activator, YC‐1, on vascular tone, cyclic GMP levels and phosphodiesterase activity

Jan Galle, Ulrike Zabel, Ulrich Hübner et al. · British Journal of Pharmacology · 1999 · 175 citations · Full text

, , +13

<i>In vitro</i>differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor‐<i>α</i>release by PDE inhibitors

Florian Gantner, R. Kupferschmidt, Christian Schudt et al. · British Journal of Pharmacology · 1997 · 144 citations · Full text

, , +9

1–5 of 51